Nesiritide

Drug Profile

Nesiritide

Alternative Names: Brain natriuretic peptide - Scios; hBNP; JNS004; Natrecor; Noratak

Latest Information Update: 08 Jun 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Scios
  • Developer Cilag AG; Quintiles Transnational; Scios
  • Class Heart failure therapies; Natriuretic peptides; Nerve tissue proteins
  • Mechanism of Action Diuretics; Guanylate cyclase modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Acute heart failure
  • No development reported Cardiomyopathies; Heart failure
  • Discontinued Chronic heart failure; Postoperative hypertension

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 15 Nov 2010 Efficacy and adverse events data from the phase III ASCEND-HF trial in Acute decompensated heart failure presented at the 83rd Annual Scientific Sessions of the American Heart Association
  • 30 Sep 2010 Scios completes enrolment in the phase III ASCEND-HF trial for Heart failure worldwide
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top